Review: taking Risperdal and Vyvanse together


Summary

Drug interactions are reported among people who take Risperdal and Vyvanse together. This review analyzes the effectiveness and drug interactions between Risperdal and Vyvanse. It is created by eHealthMe based on reports of 167 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Risperdal and Vyvanse >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Risperdal

Risperdal has active ingredients of risperidone. It is often used in schizophrenia. (latest outcomes from Risperdal 41,817 users)

Vyvanse

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Vyvanse 7,909 users)

On Jul, 23, 2016

167 people who take Risperdal, Vyvanse are studied.


Number of reports submitted per year:

Risperdal and Vyvanse drug interactions.

Drug effectiveness over time:

Risperdal:
  • < 1 month: 20.0% - (1 of 5 people)
  • 1 - 6 months: 0.0% - (0 of 8 people)
  • 6 - 12 months: 18.0% - (2 of 11 people)
  • 1 - 2 years: 0.0% - (0 of 8 people)
  • 2 - 5 years: 68.0% - (15 of 22 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 1 people)
Vyvanse:
  • < 1 month: 30.0% - (3 of 10 people)
  • 1 - 6 months: 20.0% - (1 of 5 people)
  • 6 - 12 months: 0.0% - (0 of 8 people)
  • 1 - 2 years: 60.0% - (3 of 5 people)
  • 2 - 5 years: 30.0% - (8 of 26 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 50.0% - (1 of 2 people)

Drug effectiveness by gender:

Risperdal:
  • female: 6.0% - (1 of 15 people)
  • male: 41.0% - (17 of 41 people)
Vyvanse:
  • female: 31.0% - (5 of 16 people)
  • male: 26.0% - (11 of 41 people)

Drug effectiveness by age:

Risperdal:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 54.0% - (12 of 22 people)
  • 10-19: 15.0% - (4 of 26 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 40.0% - (2 of 5 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 0.0% - (0 of 0 people)
Vyvanse:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 10.0% - (2 of 19 people)
  • 10-19: 32.0% - (9 of 28 people)
  • 20-29: 33.0% - (1 of 3 people)
  • 30-39: 40.0% - (2 of 5 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • chest pain
  • disturbance in attention
  • affect lability
  • aggression
  • crying in childhood
  • drug ineffective
  • erectile dysfunction
  • insomnia
  • pain
  • palpitations
1 - 6 months:
  • aggression
  • anger
  • blood glucose decreased
  • communication disorder
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • flushing
  • hallucination
  • hyperactivity syndrome aggravated
  • hypophagia
  • overdose
6 - 12 months:
  • asperger's disorder
  • attention deficit/hyperactivity disorder
  • decreased appetite
  • depression
  • loss of libido
  • mood altered
  • abdominal pain
  • aggression
  • agitation
  • anger
1 - 2 years:
  • tic
  • aggression
  • aggression aggravated
  • anger
  • blood glucose decreased
  • communication disorder
  • erectile dysfunction
  • fear
  • flushing
  • hallucination
2 - 5 years:
  • staring
  • fatigue aggravated
  • insomnia
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • fear
  • prolactin
  • akathisia
  • blood cholesterol increased
  • diabetic ketoacidosis
  • dizziness
5 - 10 years:
  • insomnia
not specified:
  • depression
  • aggression
  • anxiety
  • psychotic disorder
  • anger
  • chronic sinusitis
  • eczema
  • eczema eyelids
  • rhinitis allergic
  • b-cell lymphoma

Most common drug interactions by gender *:

female:
  • depression
  • anxiety
  • insomnia
  • irritability
  • aggression
  • convulsion
  • gait disturbance
  • injection site pain
  • mania
  • migraine
male:
  • anger
  • aggression
  • chronic sinusitis
  • eczema
  • eczema eyelids
  • rhinitis allergic
  • suicidal ideation
  • b-cell lymphoma
  • conjunctivitis
  • cough

Most common drug interactions by age *:

2-9:
  • anger
  • b-cell lymphoma
  • chronic sinusitis
  • conjunctivitis
  • cough
  • ear infection
  • eczema
  • eczema eyelids
  • pyrexia
  • reflux oesophagitis
10-19:
  • insomnia
  • aggression
  • mood altered
  • depression
  • anxiety
  • convulsion
  • gait disturbance
  • injection site pain
  • irritability
  • mania
20-29:
  • dental caries
  • headache
  • hot flush
  • hyperhidrosis
  • irritability
  • slurred speech
30-39:
  • agitation
  • dizziness
  • fatigue aggravated
  • hyperprolactinaemia
40-49:
  • blood cholesterol increased
  • weight decreased
  • diabetic ketoacidosis
  • obesity
  • pancreatitis
  • sleep apnoea syndrome
  • type 1 diabetes mellitus
  • alopecia
  • anxiety
  • depression
50-59:
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • abasia
  • dysarthria

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Risperdal and Vyvanse?

Can you answer these questions?

More questions for: Risperdal, Vyvanse

You may be interested in these reviews

More reviews for: Risperdal, Vyvanse

On eHealthMe, Risperdal (risperidone) is often used to treat schizophrenia. Vyvanse (lisdexamfetamine dimesylate) is often used to treat attention deficit hyperactivity disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.